What You Should Know: - The latest edition of SVB's Healthcare Investments and Exits report provides information on VC fundraising, investments and M&A and IPO trends - along with subsector analysis and video commentary for each. - Healthcare trends indicate US healthcare VC investment was healthy in 2022 despite an economic downturn. There's plenty of dry powder to deploy; however, investments and exits are slowing due to the volatile market. Trends and Insights – Healthcare
Read More
Initial Public Offering
Rev Cycle Company Ensemble Health Partners Files to Go Public
What You Should Know: - Ensemble Health Partners, Inc. (“Ensemble”), a provider of healthcare revenue cycle management solutions for hospitals and affiliated physician groups, announced it has filed to raise $649M for its initial public offering (IPO), at a valuation of $1.2B. - Ensemble is offering 29,500,000 shares of its Class A common stock at an initial public offering price between $19 and $22 per share. It also intends to grant the underwriters a 30-day option to
Read More
Pear Therapeutics Goes Public Via $1.6B SPAC Deal – Digital Health IPO
What You Should Know: - Pear Therapeutics, the leader in developing and commercializing prescription digital therapeutics to treat serious disease, and Thimble Point Acquisition Corp (Nasdaq: THMA), a special purpose acquisition company (SPAC) whose management team is associated with the Pritzker Vlock Family Office, today announced that they have entered into a definitive business combination agreement. - Pursuant to the Business Combination Agreement, upon closing of the
Read More
Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the course of the quarter, we observed $7 billion in private equity and venture capital investment across 158 companies. By comparison, Q1 of 2020 saw $3.2 billion and 127 investments. Health IT
Read More
Sharecare to Go Public in SPAC IPO Deal, Reaching $3.9B Valuation
What You Should Know: - Digital health company Sharecare and special purpose acquisition company (SPAC), Falcon Capital Acquisition Corp, today announced an agreement to merge to go public on the NASDAQ under the ticker symbol SHCR at enterprise value of $3.9B. - The transaction is expected to be funded through a combination of Falcon's $345 million of cash in trust (assuming no redemptions) supported by a $425 million fully committed PIPE at $10.00 per share and the Anthem
Read More
Signify Health Shares Soar More Than 33% in IPO, Valuing Company at Over $7.12B
What You Should Know: - Shares of Signify Health, a value-based care billing platform for in-home and bundled health services jumped more than 33% in its initial public offering (IPO), valuing the company at over $7.12B. - Today, Signify Health’s CEO Kyle Armbrester will also join the ranks among the youngest CEOs to ever take a company public – notably alongside Bumble’s CEO who also began trading on the NASDAQ today. - The company raised 564 million by offering 23.5 million
Read More
SPAC Compute Health Acquisition Prices $750M IPO, Led by Intel Chairman
What You Should Know: - Compute Health Acquisition, a SPAC company targeting the intersection of computation and healthcare announced the pricing of its $750M initial public offering (IPO) by offering 75 million units at $10. Compute Health Acquisition Corp. (the “Company”), a SPAC “blank check” company announced today that it priced its initial public offering of 75,000,000 units at $10.00 per unit. The units will be listed on The New York Stock Exchange (“NYSE”) and trade under the
Read More
Israeli Digital Health Startup G Medical Innovations Withdraws $30M US IPO
What You Should Know: - Israeli-based G Medical Innovation has withdrawn its plans for an initial public offering (IPO) on Tuesday, Nasdaq first reports. - The company originally filed
an IPO to raise $30 million by offering 5 million shares at a price range of $5
to $7 last month to list on the Nasdaq under the symbol GMVD. - The recent withdrawal marks the company's second
attempt to go public in the US, previously filing in May 2019 and withdrawing
the following August. The company
Read More
Will Nanox Disrupt The X-Ray Systems Market?
With its share price falling from more than $66 to less than $24, September was a tumultuous month for Nanox. On August 25th, the medical imaging start-up closed its initial public offering, having raised $190m from the sale of 10,555,556 ordinary shares at a price of $18 each. Money poured in as investors were sold on Nanox’s cold cathode x-ray source and the subsequent reduction in costs that it would enable, as well as the vendor’s pay-per-scan pricing model that would let the company
Read More
AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials
What You Should Know: - AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera. - AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment. AiCure,
Read More
